These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 1389478)

  • 1. Pharmacological purging of syngeneic bone marrow ex vivo: effect of treatment with doxorubicin and lonidamine on normal and leukaemic cells of DBA/2 mice.
    Sandrelli A; De Fabritiis P; Capua A; Mandelli F; Zupi G; Leonetti C
    Eur J Cancer; 1992; 28A(10):1633-6. PubMed ID: 1389478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of etoposide in combination with cyclosporin for purging multidrug-resistant leukemic cells from bone marrow in a mouse model.
    Kühl JS; Sikic BI; Blume KG; Chao NJ
    Exp Hematol; 1992 Oct; 20(9):1048-54. PubMed ID: 1468539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of doxorubicin in combination with mafosfamide for in vitro elimination of myeloid and lymphoid tumor cells from human bone marrow.
    Domenech J; Georget MT; Gihana E; Colombat P; Brémond JL; Chassaigne M; Lamagnère JP; Binet C
    Bone Marrow Transplant; 1992 Feb; 9(2):101-6. PubMed ID: 1571708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of a combined purging with mafosfamide and hyperthermia on murine haemopoietic stem cells and leukaemogenic cells.
    Gidáli J; Fehér I
    Bone Marrow Transplant; 1992 Dec; 10(6):479-83. PubMed ID: 1490197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Guanine arabinoside as a bone marrow-purging agent.
    Kurtzberg J
    Ann N Y Acad Sci; 1993 Jun; 685():225-36. PubMed ID: 8363226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction of heat-induced haemotoxicity in a hyperthermic purging protocol of murine acute myeloid leukaemic stem cells by AcSDKP.
    Wierenga PK; Dillingh JH; Konings AW
    Br J Haematol; 1997 Dec; 99(3):692-8. PubMed ID: 9401086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spermine dialdehyde, a novel ex vivo purging agent for both allogenic and autologous bone marrow transplantations.
    Lau C; Wang E; Ishaque A; Jones K; Wong B; Kimsto L; Conant J
    Int J Immunopharmacol; 1992 Aug; 14(6):1081-91. PubMed ID: 1428363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and toxicity of 9-beta-D-arabinofuranosylguanine (araG) as an agent to purge malignant T cells from murine bone marrow: application to an in vivo T-leukemia model.
    Gravatt LC; Chaffee S; Hebert ME; Halperin EC; Friedman HS; Kurtzberg J
    Leukemia; 1993 Aug; 7(8):1261-7. PubMed ID: 8350627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced cytotoxic interaction between 5-fluorouracil and 4-hydroperoxycyclophosphamide against L1210 murine leukemic cells: applicability to ex vivo purging.
    Mao XY; Higashigawa M; M'Soka T; Shimono Y; Nagata T; Inamochi H; Cao DC; Hori H; Kawasaki H; Sakurai M
    Cancer Invest; 1999; 17(7):486-93. PubMed ID: 10518193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of lonidamine combined with different DNA-damaging agents in the treatment of the MX-1 tumor xenograft.
    Pratesi G; De Cesare M; Zunino F
    Cancer Chemother Pharmacol; 1996; 38(2):123-8. PubMed ID: 8616901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluosol-DA/carbogen with lonidamine or pentoxifylline as modulators of alkylating agents in the FSaIIC fibrosarcoma.
    Teicher BA; Herman TS; Tanaka J; Dezube B; Pardee A; Frei E
    Cancer Chemother Pharmacol; 1991; 28(1):45-50. PubMed ID: 1904012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of alkylating agents by lonidamine in vivo.
    Teicher BA; Holden SA; Herman TS; Frei E
    Semin Oncol; 1991 Apr; 18(2 Suppl 4):7-10. PubMed ID: 1903216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro purging of bone marrow with mafosfamide synergizes with in vivo chemotherapy to delay the hematological recovery in a murine model of autologous bone marrow transplantation.
    Lopez M; Mary JY; Sainteny F
    Exp Hematol; 1993 Feb; 21(2):311-8. PubMed ID: 8425567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro pharmacological purging of human bone marrow is enhanced by the use of lonidamine.
    De Fabritiis P; Sandrelli A; Covelli A; Simone F; De Felice L; Pulsoni A; Zupi G; Mandelli F
    Exp Mol Pathol; 1989 Apr; 50(2):210-9. PubMed ID: 2707384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Purging of acute myeloid leukaemia cells from stem cell grafts by hyperthermia: enhancement of the therapeutic index by the tetrapeptide AcSDKP and the alkyl-lysophospholipid ET-18-OCH(3).
    Wierenga PK; Setroikromo R; Vellenga E; Kampinga HH
    Br J Haematol; 2000 Dec; 111(4):1145-52. PubMed ID: 11167754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro potentiation by lonidamine of the cytotoxic effect of adriamycin on primary and established breast cancer cell lines.
    Savini S; Zoli W; Nanni O; Volpi A; Frassineti GL; Magni E; Flamigni A; Amadori A; Amadori D
    Breast Cancer Res Treat; 1992; 24(1):27-34. PubMed ID: 1463869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lonidamine as a modulator of alkylating agent activity in vitro and in vivo.
    Teicher BA; Herman TS; Holden SA; Epelbaum R; Liu SD; Frei E
    Cancer Res; 1991 Feb; 51(3):780-4. PubMed ID: 1988117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Purging leukemia remission marrows with alkyl-lysophospholipids, preclinical and clinical results.
    Vogler WR; Olson AC; Berdel WE; Okamoto S; Glasser L
    Prog Clin Biol Res; 1990; 333():1-18; discussion 19-20. PubMed ID: 2308973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of mafosfamide (ASTA-Z-7654) on the clonogenic cells in precursor-B acute lymphoblastic leukaemia: significance for ex vivo purging of bone marrow for autologous transplantation.
    Makrynikola V; Kabral A; Bradstock KF
    Bone Marrow Transplant; 1991 Nov; 8(5):351-5. PubMed ID: 1768969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combinations of 4-hydroperoxycyclophosphamide (4-HC) and cisplatin for bone marrow purging in autologous marrow transplantation: an update.
    Peters RH; Brandon CS; Avila LA; Gale GR; Stuart RK
    Prog Clin Biol Res; 1990; 333():57-68. PubMed ID: 2309001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.